2016 Speakers included:

  • Mr Kevin Baughan at World Precision Medicine Congress 2016
    Mr Kevin Baughan
    Director of Technology and Innovation
    Innovate UK
  • Dr Richard Buller at World Precision Medicine Congress 2016
    Dr Richard Buller
    Vice President and Head, Clinical Development
    Pfizer Oncology
  • Professor Peter Johnson at World Precision Medicine Congress 2016
    Professor Peter Johnson
    Chief Clinician
    Cancer Research UK
  • Mr Alastair Kent OBE at World Precision Medicine Congress 2016
    Mr Alastair Kent OBE
    Director
    Genetic Alliance U.K.
  • Prof Mark Lawler at World Precision Medicine Congress 2016
    Prof Mark Lawler
    Chair in Translational Cancer Genomics
    Queens University Belfast
  • Dr Niven Narain at World Precision Medicine Congress 2016
    Dr Niven Narain
    Co-Founder, President & CEO
    Berg Llc
  • Dr Julia Wilson at World Precision Medicine Congress 2016
    Dr Julia Wilson
    Associate Director
    Wellcome Trust Sanger Institute

 

PROSPECTUS DOWNLOAD

 

 

 

 

 

 

“It was a great meeting. It was such a cool idea having the meetings running at the same time, so they are interlinked but we mingle in the networking sessions, it made for an interesting and very productive event.”​ 

 

Associate Director, Wellcome Trust Sanger Institute

 

 

 

 

 

Key topic areas at World Precision Medicine Congress 2017 include:

Data & services: Big data, patient cohorts, data security
Diagnostics & e-health: Dx, pharma CDx development, biomarkers, e-health and connectivity
Infrastructure & investment: Cluster development, incubator/accelerator facilities, funding
Clinical programmes: Rare diseases, oncology, infectious diseases and other complex condition

To find out how you can get involved for 2017, download the sponsorship prospectus today!

PROSPECTUS DOWNLOAD

 

Why Sponsor?

 

 

Don’t miss the chance to differentiate yourself from the competition by demonstrating your expertise to cell therapy, gene therapy, genomics and precision medicine stakeholders.

 

 

 

 

 

“It was a good meeting. I did lots of networking and met some very interesting people.”

 

Professor of Osteoarticular Pathology, Head of Manchester Medical School, Director of the MMPathIC, the Manchester MRC/ EPSRC Molecular Pathology Node, University of Manchester and Manchester Academic Health Sciences Centre

 

 

 

 

 

 

The 2017 Congress will once again be co-located with: